News
News and Announcements
August 9, 2022
ClearLight Closes Lab Services and Offers Expert Consulting Services
June 6, 2022
Use 3D Histopathology to Improve Experimental Designs
March 29, 2022
ClearLight Bio Exhibiting at AACR 2022, April 10-13
March 22, 2022
Dr. Sharla White Featured on Society of Toxicology Panel
March 21, 2022
ClearLight Biotechnologies, Inc., today announced that it has added a customized MuVi SPIM CS Light-Sheet Microscope from Luxendo, a Bruker company, to its portfolio of imaging solutions.
March 17, 2022
Bruker | ClearLight Webinar – Imaging Complex Structure with CLARITY and Light-Sheet Fluorescence Microscopy
March 11, 2022
Antibody Feasibility for CLARITY: What does it mean?
February 17, 2022
Dr. White Featured on Digital Pathology Place Podcast
January 26, 2022
ClearLight at Precision in Drug Discovery and Development Summit West 2022
December 9, 2021
Dr. White Featured on Her Royal Science Podcast
November 27, 2021
CLARITY Tissue Clearing Kits: Video Intro
November 15, 2021
ClearLight Bio Lab Services Now Available on Scientist.com
October 8, 2021
Dr. Sharla White Featured on People of Pathology Podcast
September 27, 2021
ClearLight Bio Exhibiting at SITC 2021, November 10-14
September 8, 2021
AACR Webinar – Enter the Microenvironment: New Opportunities in Tissue Clearing and 3D Imaging
August 23, 2021
Dr. Sharla White Featured in Life Sciences Review
August 11, 2021
Better Understanding of the Tissue Microenvironment
July 28, 2021
A CRO of a Different Breed
July 5, 2021
Get More Value from your Tissue Samples with a Retrospective Study
June 1, 2021
ClearLight will be at Precision in Drug Discovery and Preclinical Virtual Summit (East Coast) 2021
May 7, 2021
ClearLight will be at BIO Digital 2021
March 16, 2021
ClearLight Biotechnologies Announces Japanese Distributor Filgen
March 1, 2021
Implantable Device Case Study
February 2, 2021
ClearLight will be at Immuno-Oncology 360° 2021, happening February 23-26, 2021!
October 10, 2020
ClearLight Biotechnologies Announces CLARITY Tissue Clearing Kits
January 28, 2020
ClearLight Biotechnologies Announces Issuance of U.S. Patent No. 10,545,075
September 10, 2019
ClearLight Biotechnologies Signs an Exclusive License Agreement to Develop and Commercialize the CRYSTAL Technology, Invented at the University of Zurich and the University Hospital Zurich
August 13, 2019
Three-dimensional Imaging and Quantitative Analysis in CLARITY Processed Breast Cancer Tissues
April 11, 2019
ClearLight Biotechnologies and Researchers at the Indiana University’s Melvin and Bren Simon Cancer CenterAnnounce the publication of “Three-dimensional Imaging and Quantitative Analysis in CLARITY Processed Breast Cancer Tissues, “in Scientific Reports-Nature.
March 29, 2019
ClearLight Biotechnologies to Present Data on the Multi-sample automation and 3D analysis of CLARITY processed tissue
January 8, 2019
ClearLight Biotechnologies, Inc (ClearLight): Developing a Next-Generation 3D Tissue Processing Platform by Leveraging CLARITY is recognized as one of “The 20 Most Disruptive Healthcare Solution Providers 2018.”
November 13, 2018
ClearLight Biotechnologies, Inc (ClearLight) is recognized as one of the “15 Most Promising BioTech Startups of 2018”.
October 23, 2018
ClearLight Biotechnologies, Inc (ClearLight) (Formerly: ClearLight Diagnostics, LLC) Announces a Company Name Change and the Introduction of a Pilot Laboratory Service Model Based on the CLARITY Technology
September 26, 2018
ClearLight Diagnostics Announces the Appointment of Laurie Goodman, Ph.D. as Chief Executive Officer
July 27, 2018
Three-dimensional intact-tissue sequencing of single-cell transcriptional states
May 20, 2018
Hydrogel-Tissue Chemistry: Principles and Applications
May 8, 2018
ClearLight Diagnostics Announces the Appointment of Laurie Goodman, PhD as Interim Chief Executive Officer and the Close of an Additional Round of Funding
January 3, 2018
ClearLight Diagnostics to Present at the 10th Annual Biotech Showcase™
December 4, 2017
ClearLight Diagnostics to Present Data on the 3D Imaging of Biomarkers in Core Needle Biopsies of Breast Cancer Patients
November 7, 2017
ClearLight Diagnostics Licenses Exclusive Intellectual Property Rights for 3D Visualization, Image Processing, and Novel CLARITY-based Tissue Clearing Instrumentation
July 19, 2017
Pathways to clinical CLARITY: volumetric analysis of irregular, soft, and heterogeneous tissues in development and disease
May 2, 2017
ClearLight Diagnostics and Researchers at the Indiana University’s Melvin and Bren Simon Cancer Center Announce a Collaboration to Profile the Tumor Microenvironment in Patients with Breast Cancer
April 5, 2017
Poster #5915: Three-dimensional (3-D) Multiplex Imaging of Biomarkers in Tumor Tissue
March 29, 2017
ClearLight Diagnostics to Present Data on the Multiplex 3D Imaging of the Tumor Microenvironment in a Variety of Preclinical and Clinical Cancer Models
December 6, 2016
ClearLight Diagnostics Raises $3.5M
November 8, 2016
ClearLight Diagnostics Licenses Exclusive Intellectual Property Rights from Stanford University for SPED microscopy and RNA Interrogation Technology in CLARITY Processed Tissue Samples
October 5, 2016
ClearLight Diagnostics and the OHSU Center for Spatial Systems Biomedicine Collaborate to Define Tumor Microenvironment in Pancreatic Cancer
October 3, 2016
A Look Inside the Brain
September 15, 2016
ClearLight Diagnostics Announces the Appointment of Laurie Goodman, PhD to its Executive Staff
February 12, 2016
Multiplexed Intact-Tissue Transcriptional Analysis at Cellular Resolution
October 1, 2015
ClearLight Diagnostics Licenses Intellectual Property Rights from Stanford University for Tissue Processing and Imaging Technologies CLARITY and COLM
May 1, 2015
ClearLight Diagnostics Announces the Appointment of Sarah McCurdy, MBA as its Chief Executive Officer
May 17, 2013
Structural and molecular interrogation of intact biological systems
April 30, 2013
Nature Posts CLARITY Video
February 3, 2013
CLARITY for mapping the nervous system
